UBS Group
YMAB icon

UBS Group’s Y-mAbs Therapeutics YMAB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.03M Buy
229,072
+137,496
+150% +$620K ﹤0.01% 4338
2025
Q1
$406K Buy
91,576
+52,644
+135% +$233K ﹤0.01% 4822
2024
Q4
$305K Sell
38,932
-5,654
-13% -$44.3K ﹤0.01% 5013
2024
Q3
$586K Buy
44,586
+25,582
+135% +$336K ﹤0.01% 3977
2024
Q2
$230K Sell
19,004
-18,543
-49% -$224K ﹤0.01% 4462
2024
Q1
$611K Buy
37,547
+803
+2% +$13.1K ﹤0.01% 3940
2023
Q4
$251K Buy
36,744
+17,211
+88% +$117K ﹤0.01% 4458
2023
Q3
$106K Sell
19,533
-1,534
-7% -$8.36K ﹤0.01% 4686
2023
Q2
$143K Sell
21,067
-55,196
-72% -$375K ﹤0.01% 4682
2023
Q1
$382K Buy
+76,263
New +$382K ﹤0.01% 3890
2022
Q4
Sell
-12,594
Closed -$182K 9867
2022
Q3
$182K Sell
12,594
-12,975
-51% -$188K ﹤0.01% 4150
2022
Q2
$387K Sell
25,569
-108,608
-81% -$1.64M ﹤0.01% 3518
2022
Q1
$1.59M Buy
134,177
+69,728
+108% +$828K ﹤0.01% 2844
2021
Q4
$1.05M Buy
64,449
+38,890
+152% +$631K ﹤0.01% 3411
2021
Q3
$729K Buy
25,559
+24,207
+1,790% +$690K ﹤0.01% 3480
2021
Q2
$45K Buy
1,352
+1,247
+1,188% +$41.5K ﹤0.01% 5470
2021
Q1
$3K Buy
105
+50
+91% +$1.43K ﹤0.01% 7497
2020
Q4
$3K Buy
55
+39
+244% +$2.13K ﹤0.01% 6990
2020
Q3
$1K Sell
16
-203
-93% -$12.7K ﹤0.01% 6963
2020
Q2
$9K Sell
219
-4,922
-96% -$202K ﹤0.01% 6243
2020
Q1
$134K Buy
5,141
+4,941
+2,471% +$129K ﹤0.01% 4189
2019
Q4
$6K Sell
200
-15,583
-99% -$467K ﹤0.01% 6462
2019
Q3
$411K Buy
15,783
+13,423
+569% +$350K ﹤0.01% 3872
2019
Q2
$54K Buy
2,360
+887
+60% +$20.3K ﹤0.01% 5002
2019
Q1
$39K Sell
1,473
-2,201
-60% -$58.3K ﹤0.01% 4919
2018
Q4
$75K Buy
+3,674
New +$75K ﹤0.01% 4900